Search results for reports

Environmental Contamination

Documentation of Environmental Contamination 1. Conner T, Anderson R, Sessink PJM et al. Surface contamination with antineoplastic agents in six cancer centers in Canada and the United States. Am J Health-System Pharm. 1999; 56: 1427-1432. Signifi

Clinical Evidence of Risk

Our News & Press

Press Releases June 9, 2011 NEW! Carmel Pharma Gives Back to the Community Read More May 9, 2011 NEW! The PhaSeal System Helps Comply with New Legislation Using PhaSeal Contributes to a Reduced Exposure Potential for Healthcare Workers Re

Health Hazards

Documentation of Health Hazards 1. McDiarmid M, Oliver M et al. Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. JOEM. 2010; 52: 1028-1034. Biologically important exposure to genotoxic drugs is apparently occurring in

Understanding the Risk

Risk of Exposure Increasing Risk of Hazardous Drug Exposure World Health Organization predicts a 50% increase of cancer cases over the next 20 years Increased number of cancer cases and more potent chemotherapy drugs only elevate risk fo

Safe Handling Awareness

Safe Handling Awareness National Safe Handling Awareness Month and Day At Carmel Pharma, we’re proud to be the official sponsor of National Safe Handling Awareness Month (April) and Day (April 20), and we’re glad to encourage safe handling

Home

Special investigation details how chemotherapy drugs pose a risk to the healthcare workers who handle them. Watch now PhaSeal’s streamlined design and universally compatible components make the System easy to use from preparati

PhaSeal Clinical Studies

PhaSeal Clinical Studies Studies evaluating fluid leakage during preparation and administration Jorgenson J, Spivey S, Au C et al. Contamination comparison of transfer devices intended for han